Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.88
-0.14 (-1.08%)
At close: Aug 26, 2026, 4:00 PM EDT
12.85
-0.03 (-0.23%)
After-hours: Aug 26, 2026, 7:30 PM EDT
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $442.48 million as of August 26, 2026. Its market cap has increased by 27.60% in one year.
Market Cap
442.48M
Enterprise Value
258.60M
1-Year Change
27.60%
Ranking
Category
Stock Price
$12.88
ChartMarket Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $442.48M, a decrease of -80.13%. That is a compound annual growth rate of -12.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 442.48M | -2.99% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 481.10M |
| Ocugen | 474.75M |
| Compass Therapeutics | 455.62M |
| Inhibikase Therapeutics | 455.19M |
| Arcturus Therapeutics Holdings | 438.85M |
| Vogenx | 438.82M |
| Atea Pharmaceuticals | 435.51M |
| Larimar Therapeutics | 434.23M |